- You are here:
- Home »
- Blog
Myeloma- Is Stem Cell Transplant a Choice or Necessity?
In this presentation, Dr. Tomer Mark argues that it is not necessary for (NDMM) patients to achieve a complete remission (CR) and minimum residual disease (MRD), and that transplant is therefore unneccessary. If
Continue readingMyeloma- Stem Cell Transplant
Why do myeloma patients undergo a stem cell transplant? Will you live longer by undergoing aggressive, high dose chemotherapy? The study linked below says no. “Finally, in 1995, the first randomized
Continue readingMultiple Myeloma Therapy- Allogeneic BMT W/ Supplements
I believe that the fact that I was young and healthy (vegan/raw foodist) at the time of diagnosis, and that I consulted with a Naturopath as to what supplements to take while going through multiple myeloma
Continue readingMultiple Myeloma Chemotherapy- Delay Autologous Stem Cell Transplantation
The outstanding efficacy seen with regimens (mm chemotherapy) based on novel agents has led to a questioning of the frontline treatment paradigm with respect to ASCT. A diagnosis of multiple myeloma (MM)
Continue readingNatural ways to prevent oral cancer
In the US, over 53000 adults suffer from oral cancer and are one of the most common types of cancer in men. Men are more vulnerable to get diagnosed with it. As per the studies, antioxidants such as vitamin
Continue readingMultiple Myeloma Diagnosis- Frailty Index Predicts Myeloma Outcome
The use of this ECOG PS–containing frailty scale as a predictive measure of clinical outcomes in patients with transplant-ineligible Newly Diagnosed Multiple Myeloma My guess is that if you’re
Continue readingMultiple Myeloma Therapies- Why Chemotherapy May Not Work for African Americans-
“Though African-American men are three times more likely to be diagnosed with multiple myeloma…most scientific research on the disease has been based on people of European descent…” Fact:
Continue readingMultiple Myeloma Clinical Trials for ASCT Misleading?
The median progression-free survival (PFS) and overall survival (OS) were significantly higher among (myeloma) patients who were trial-eligible Multiple myeloma clinical trials are said to be “the
Continue readingMyeloma Diagnosis- RVd, ASCT, Now or Later?
In conclusion, we found no statistically significant differences in (MM) PFS and OS between the early versus late ASCT groups. Hi David-My father in-law just emailed me your newly-updated Multiple Myeloma
Continue readingMinimal Residual Disease (MRD) in Multiple Myeloma
“Overall survival was favorable among MRD-negative patients, as well as among patients with complete response.” After 25 years and reading 000’s of studies, I’m cynical when it
Continue readingCryotherapy Reduces Peripheral Neuropathy?
“The condition (CIPN) can cause pain, numbness, and tingling, affect quality of life and often result in treatment delays, (to multiple myeloma patients) reduced treatment doses, or treatment discontinuation..” Peripheral
Continue readingRadiation Tattoos and Cancer Survivorship: Helpful Marker or Emotional Trigger?
Radiation tattoos and Cancer- Radiation therapy tattoos help guide treatment, but some cancer survivors struggle with the emotional impact of permanent reminders. Learn about the psychological and practical
Continue reading